IFNG and neoplasm: The human CD56+ cells are able to produce IFN-γ in response to polyI:C and IL-15 and cells from reconstituted mice are able to respond to the human NK-sensitive K562 erythroleukemia cell line by producing IFN-γ and inhibiting tumor growth both in vitro and in vivo.